ETHEL ESTRADA: Open Payments
NPI 1134524838 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 26 payments from 15 companies in 2025. Trend: 2023 $166 · 2024 $326 · 2025 $818
Food & beverage: $719Education: $99
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 2 | $131 |
| GlaxoSmithKline, LLC. | 5 | $123 |
| Syndax Pharmaceuticals, Inc. | 2 | $108 |
| PharmaEssentia USA Corporation | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Azurity Pharmaceuticals, Inc. | 3 | $51 |
| ABBVIE INC. | 1 | $33 |
| PFIZER INC. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
Products named: OJJAARA, Doptelet, BESREMI, ICLUSIG, DANZITEN, EPKINLY, BOSULIF, Xospata.
Industry payments across TX — which companies pay providers there.
